APA (7th ed.) Citation

M, K., Y, E., & Y, K. (2025). ASO Author Reflections: Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02)-A Phase 2 Clinical Trial. Annals of surgical oncology, 32(10), 7452. https://doi.org/10.1245/s10434-025-17876-8

Chicago Style (17th ed.) Citation

M, Kitago, Endo Y, and Kitagawa Y. "ASO Author Reflections: Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02)-A Phase 2 Clinical Trial." Annals of Surgical Oncology 32, no. 10 (2025): 7452. https://doi.org/10.1245/s10434-025-17876-8.

MLA (9th ed.) Citation

M, Kitago, et al. "ASO Author Reflections: Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02)-A Phase 2 Clinical Trial." Annals of Surgical Oncology, vol. 32, no. 10, 2025, p. 7452, https://doi.org/10.1245/s10434-025-17876-8.